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This paper identifies in detail the importance of vaccinations, focusing primarily on the category 
of school-aged children.  All 12 vaccines are discussed individually, recognizing the 
disease/diseases they are protecting against, benefits of the vaccine, how and to whom the 
vaccine is administered, contraindications for the immunization, and risks associated with each 
vaccination.  The information used in this project is from a combination of scholarly peer-
reviewed journal articles, medical texts, and information from the Centers for Disease Control 
and Prevention (CDC).  It addresses all regulated childhood vaccinations including hepatitis B 
(Hep B); haemophilus influenzae type b (Hib); diphtheria, tetanus, and pertussis (DTaP/Tdap); 
inactivated polio vaccine (IPV); pneumococcal conjugate vaccine (PCV13); rotavirus; measles, 
mumps, and rubella (MMR); varicella; hepatitis A (Hep A); meningococcal (MenACWY); 
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The Importance of Immunizations in School-Aged Children 
To vaccinate, or not to vaccinate... that is the question.  In regards to vaccinations, there 
is a variety of opinionated information circulating in the media nowadays.  While some parents 
and caregivers opt-in for their children to receive vaccines without question, there are still those 
who are anti-immunizations.  Regardless of stance on the matter, it is important that parents and 
caregivers of school-aged children are informed and understand how critical vaccinations can be 
to not only their children, but to others around them as well.   
Immunizations protect people from a variety of devastating and sometimes even deadly 
disease processes.  They are typically administered intramuscularly, orally, and/or intranasally.  
The Center for Disease Control and Prevention (CDC) states “vaccines help develop immunity 
by imitating an infection, but this ‘imitation’ infection does not cause illness. Instead it causes 
the immune system to develop the same response as it does to a real infection so the body can 
recognize and fight the vaccine-preventable disease in the future” (para. 4).  Vaccines not only 
protect the individual receiving the immunization, but since vaccinated people will be less likely 
to contract the disease, those around them that are too young to receive the vaccines will be at a 
decreased chance of falling ill from that disease as well.   
According to Stern and Markel (2005), the first vaccine was developed in the 1790s, 
dating the history of immunizations back approximately two centuries.  Since the discovery of 
the first vaccine, several others have been developed and implemented as routine health practices 
for people of all ages.  When focusing on school-aged children, the CDC (2018) states 
“Vaccination is one of the best ways parents can protect infants, children, and teens from 16 
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potentially harmful diseases that can be very serious, may require hospitalization, or even be 
deadly” (para. 1).  The 16 diseases that the CDC is referring to are hepatitis B,  haemophilus 
influenzae type b, diphtheria, tetanus, pertussis, polio,  pneumococcal disease, rotavirus, measles, 
mumps, rubella, varicella (chickenpox), hepatitis A, meningococcal disease, influenza, and the 
human papillomavirus.  The vaccinations for these 16 diseases are most commonly divided into 
twelve individual immunizations, sometimes combining more than one vaccination into one 
injection.  It is imperative for parents and caregivers to know the disease which the vaccine is 
protecting against, benefits of the vaccine, how and to whom the vaccine is administered, 
contraindications for the immunization, and risks associated. 
Hepatitis B Vaccine 
The Disease 
Hepatitis B is an infection of the liver that is directly related to the inflammation of the 
hepatocytes, also known as the liver cells (Branco, Oliveira, Silva, Santos, & Guimarães, 2017).  
A diagnosis of hepatitis B can be described as acute (lasting less than 6 months) or chronic in 
nature (lasting greater than 6 months).  The CDC (2015) describes the diagnosis of hepatitis B as 
the following: 
Hepatitis B is a liver infection caused by the Hepatitis B virus (HBV). Hepatitis B is 
transmitted when blood, semen, or another body fluid from a person infected with the 
Hepatitis B virus enters the body of someone who is not infected. This can happen 
through sexual contact; sharing needles, syringes, or other drug-injection equipment; or 
from mother to baby at birth. For some people, hepatitis B is an acute, or short-term, 
illness but for others, it can become a long-term, chronic infection. Risk for chronic 
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infection is related to age at infection: approximately 90% of infected infants become 
chronically infected, compared with 2%–6% of adults. Chronic Hepatitis B can lead to 
serious health issues, like cirrhosis or liver cancer. The best way to prevent Hepatitis B is 
by getting vaccinated. (para. 1) 
Other modes of transmission of hepatitis B that are not listed above include sharing items such as 
toothbrushes or razors, and even contact with the blood or open sores of an infected person 
(CDC, 2018). 
Common signs and symptoms of hepatitis B include but are not limited to “fever, fatigue, 
loss of appetite, nausea, and/or vomiting, jaundice (yellow skin or eyes, dark urine, clay-colored 
bowel movements), pain in muscles, joint pain, and stomach pain” (CDC, p. 1).  When it comes 
to clinical findings, elevated liver enzymes are indicative of a liver inflammatory response or 
infectious disease.  Liver enzymes typically tested to confirm diagnosis include Alanine 
transaminase (ALT), Aspartate transaminase (AST), Gamma-glutamyl transpeptidase (GGT), 
and Alkaline phosphatase (ALP).  Further imaging such as a liver ultrasound is a usual 
diagnostic tool used in confirming a hepatitis B infection as well. 
Benefits of the Vaccine 
According to the CDC (2018) approximately 2,000 people in the United States die from 
hepatitis B-related liver disease every year.  To lessen the chances of infection by hepatitis B and 
its complications such as liver cancer and cirrhosis, one should receive the hepatitis B 
vaccination at the given times set by the CDC (CDC, 2018).   The CDC (2018) reports that the 
hepatitis B vaccination is “made from parts of the hepatitis B virus” (p. 1).  However, hepatitis B 
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cannot be contracted from receiving the vaccine.  “Safe and effective vaccines against hepatitis B 
have been available since 1982” (World Health Organization [WHO], 2017).   
Administration of the Vaccine 
Currently in the United States, the hepatitis B vaccine is the only vaccine received at 
birth.  This immunization is administered via the intramuscular route, typically in the lateral 
thigh or deltoid muscle.  According to the CDC recommended schedule, it is then administered 
again at one to two months of age and between six to eighteen months of age for the third and 
final dose (CDC, 2018). 
The CDC (2018) states that “all children and adolescents younger than 19 years of age 
who have not yet gotten the vaccine should also be vaccinated” (p. 1).  The CDC (2018) clarifies 
that individuals who should also receive the hepatitis B vaccine include but are not limited to: 
• People whose sex partners have hepatitis B 
• Sexually active persons who are not in a long-term monogamous relationship 
• Persons seeking evaluation or treatment for a sexually transmitted disease 
• Men who have sexual contact with other men 
• People who share needles, syringes, or other drug-injection equipment 
• People who have household contact with someone infected with the hepatitis B virus 
• Health care and public safety workers at risk for exposure to blood or body fluids 
• Residents and staff of facilities for developmentally disabled persons 
• Persons in correctional facilities 
• Victims of sexual assault or abuse 
• Travelers to regions with increased rates of hepatitis B 
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• People with chronic liver disease, kidney disease, HIV infection, or diabetes 
• Anyone who wants to be protected from hepatitis B (p. 1) 
Risks of the Vaccine 
In regards to the hepatitis B vaccine, there are a few contraindications for receiving this 
immunization.  It is appropriate for people who are acutely ill, with something such as a cold, to 
still receive the vaccine.  However, if a person has a more serious ailment such as the flu or a 
stomach virus, the hepatitis B vaccine is not recommended as the vaccine may worsen symptoms 
(i.e. fever, diarrhea, etc.).   The CDC (2018) also states that if a patient has any severe allergies 
to any part of the hepatitis B vaccination such as hives, swelling of the face, or difficulty 
breathing or swallowing, it is contraindicated for that person. 
Risks for receiving the hepatitis B vaccine include both minor and more serious reactions.  
Minor reactions include fever and localized soreness where the injection was administered.  
More severe reactions include fainting after the injection is given, long-lasting pain at the 
injection site, and allergic reactions such as hives, difficulty breathing, swelling of the face and 
throat, tachycardia, weakness and dizziness.  Typically, these reactions will appear within a few 
minutes to a few hours after the vaccine is administered (CDC, 2018). 
Furthermore, it is important to report that there have been no correlations between the 
hepatitis B vaccine and any chronic illnesses.  WHO (2017) states: 
Numerous long-term studies have found no evidence of serious adverse events causally 
linked to hepatitis B vaccination. Data do not indicate a causal association between 
hepatitis B vaccine and neurological disease (including Guillain-Barré syndrome and 
multiple sclerosis), diabetes mellitus, demyelinating disorders, chronic fatigue syndrome, 
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arthritis, autoimmune disorders, asthma, hair loss, or sudden infant death syndrome. (p. 
382-383) 
 In conclusion, the hepatitis B vaccine is important for school-aged children to aid in 
preventing debilitating diseases such as cirrhosis and liver cancer which can be directly 
associated with the hepatitis B disease.  By adhering to the CDC guidelines for administration of 
the vaccine, chances of contracting the hepatitis B disease can be decreased drastically.  
Although some people may still opt out of vaccinations, benefits of the hepatitis B vaccine 
greatly outweigh the risks. 
Hib Vaccine 
The Disease 
Haemophilus influenzae type b (Hib) is a type of bacteria that is known to cause a variety 
of different infections.  These infections can range from a mild ear infection to something as 
serious as a deadly infection of the bloodstream.  The CDC (2018) reports the following: 
Doctors consider some of these infections “invasive.” Invasive disease happens when the 
bacteria invade parts of the body that are normally free from germs.  The most common 
types of invasive disease caused by H. influenzae are: 
• Pneumonia (lung infection) 
• Bacteremia (bloodstream infection) 
• Meningitis (infection of the tissue covering of the brain and spinal cord) 
• Epiglotittis (swelling in the throat) 
• Cellulitis (skin infection) 
• Infectious arthritis (inflammation of the joint) (p. 1) 
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Hib infection is best identified by signs and symptoms of each of the individual disease 
processes.  According to the CDC (2018), pneumonia is characterized by fever, chills, 
headaches, cough, shortness of breath, chest pain, excessive sweating (perfusion), fatigue, and 
muscle pain or aches.  Bacteremia signs and symptoms include fatigue, fever and chills, 
abdominal pain, nausea (with or without vomiting), diarrhea, altered mental status, anxiety, 
shortness of breath and/or difficulty breathing.  Characteristics of meningitis can include a severe 
headache, stiffness of the neck, fever, nausea (with or without vomiting), photophobia (light 
sensitivity related to the eyes), and confusion.  Diagnosis of Hib infection is obtained by 
laboratory confirmation of the H. influenzae bacteria via blood or spinal fluid specimens. 
Hib infection is transmitted via person to person contact.  This means that a person can 
contract this infection simply by being around someone who has the Hib bacteria.  The CDC 
(2015) states that the Hib disease typically affects children under the age of 5.  They state that 
before the Hib vaccine, “Hib was the leading cause of bacterial meningitis among children under 
5 years old in the United States” (p. 1).  Meningitis, as stated previously, is an infection of the 
tissue lining the brain and spinal cord and can lead to serious problems such as deafness and 
brain damage (CDC, 2015).  Furthermore, the CDC (2015) states that approximately “20,000 
children in the United States under 5 years old got Hib disease each year, and about 3% - 6% of 
them died” (p. 1). 
Benefits of the Vaccine 
When it comes to the effectiveness of the Hib vaccine, it is best to look at the statistics.  
WHO (2006) reports: 
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Vaccines are the only public health tool capable of preventing the majority of cases of 
serious Hib disease.  The vaccines are formulated either as single antigens or as part of 
combination vaccines. Hib vaccines are safe and efficacious even when administered in 
early infancy; they are included in routine childhood vaccination programmes in more 
than 90 countries in all regions of the world. As a consequence, invasive Hib disease has 
been practically eliminated in many industrialized countries, and its incidence has been 
dramatically reduced in some parts of the developing world. (p. 446) 
In addition, the CDC (2015) reiterates the importance of the Hib vaccine stating that since 
implementing the immunization, there has been a 99% decrease in cases of invasive Hib disease.  
Without vaccinating against Hib, numerous children would be infected by this potentially deadly 
disease. 
Administration of the Vaccine 
 There are several different brands of the Hib vaccine available including ones that only 
cover Hib and also combination vaccines that include multiple immunizations into one single 
injection.  Regardless of the brand, all are administered via the intramuscular route.  Depending 
on whether a single or combination vaccine is used, the CDC (2015) recommends that the 
vaccine be given in either 3 or 4 doses following this schedule: 
• Initial dose:            2 months old 
• 2nd dose:                4 months old 
• 3rd dose:                6 months old (depending on the brand of the vaccine) 
• 4th dose/ booster:  12-15 months of age 
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The Hib vaccine is safe to administer with other vaccines and is most commonly paired with the 
polio vaccine, tetanus diphtheria and pertussis vaccine, rotavirus immunization, hepatitis B 
vaccine and the pneumonia vaccine since these have a similar schedule for administration. 
Apart from the scheduled recommendations by the CDC, the Hib vaccine is also 
indicated for children and adults over the age of 5 with asplenia or sickle cell disease, pre-
operation for a splenectomy, or after a bone marrow transplant (CDC, 2015).  It may also be 
given to patients with human immunodeficiency virus (HIV) between the ages of 5-18.  
Otherwise, people over the age of 5 do not need the Hib vaccine (CDC, 2015). 
Risks of the Vaccine 
In contrast, the Hib vaccine is not suitable for some populations.  The CDC states that the 
“Hib vaccine should not be given to infants younger than 6 weeks of age” (p. 2).  As with the 
hepatitis B vaccine, the Hib immunization can be given during acute illnesses, but should be 
avoided during serious ones.  The CDC (2015) also reports that people who are allergic to any 
portion of the Hib vaccine or if they have had a serious reaction to a previous dose of the 
immunization should avoid it. 
In conclusion, the Hib vaccination can protect people from contracting the H. influenzae 
bacteria, thus protecting them from various disease processes such as pneumonia, meningitis, 
and bacteremia, just to name a few.  As it relates to administration, healthcare providers should 
adhere to the CDC guidelines using a 3 or 4 step vaccination schedule depending on the brand of 
the vaccine.  Benefits, yet again, outweigh the risks of not receiving the Hib vaccine, especially 
for children under the age of 5 years old since the H. influenzae bacteria can cause severe and 
sometimes deadly illnesses. 
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Diphtheria, Tetanus, and Pertussis Vaccine 
The Diseases 
 According to the CDC (2015), diphtheria is a disease caused by the bacteria 
Corynebacterium diphtheriae and is transmitted via person to person contact by secretions such 
as sneezing or coughing.  The CDC describes diphtheria as causing “a thick covering in the back 
of the throat. It can lead to breathing problems, paralysis, heart failure, and even death” (CDC, 
2015).  Once the bacteria adheres to the throat, it can form a toxin (poison) causing symptoms 
such as weakness, fever, sore throat, and swollen glands in the neck (CDC, 2018).   
 Tetanus, on the other hand, causes a painful tightening of the muscles.  The CDC (2017) 
describes tetanus as: 
Tetanus is an infection caused by bacteria called Clostridium tetani. When the bacteria 
invade the body, they produce a poison (toxin) that causes painful muscle contractions. 
Another name for tetanus is “lockjaw”. It often causes a person’s neck and jaw muscles 
to lock, making it hard to open the mouth or swallow.  (para. 1) 
Tetanus is transmitted by the C. tetani bacteria entering the body through a break in the skin via 
contaminated soil or dust (CDC, 2017).  Common signs and symptoms of tetanus are: 
• Cramping of the jaw 
• Muscle spasms (most commonly in the abdomen) 
• All over muscle stiffness 
• Difficulty swallowing 
• Seizures 
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• Headache 
• Sweating and fever 
• Changes in blood pressure and an elevated heart rate 
Pertussis, also known as Whooping Cough, is a highly contagious respiratory disease 
cause by the bacterium Bordetella pertussis (CDC, 2017).  The CDC (2017) reports: 
Pertussis is known for uncontrollable, violent coughing which often makes it hard to 
breathe. After cough fits, someone with pertussis often needs to take deep breaths, which 
result in a “whooping” sound. Pertussis can affect people of all ages, but can be very 
serious, even deadly, for babies less than a year old. (para. 1) 
Like diphtheria, pertussis is transmitted from person-to-person contact by either coughing or 
sneezing.  Signs that someone may have pertussis include both early and late symptoms.  
According to the CDC (2017): 
Early symptoms can last for 1 to 2 weeks and usually include: 
• Runny nose 
• Low-grade fever (generally minimal throughout the course of the disease) 
• Mild, occasional cough 
• Apnea- a pause in breathing (in babies 
After 1 to 2 weeks and as the disease progresses, the traditional symptoms of pertussis 
may appear and include: 
IMMUNIZATIONS IN SCHOOL-AGED CHILDREN  14 
 
   
 
• Paroxysms (fits) of many, rapid coughs followed by a high-pitched “whoop” 
sound 
• Vomiting (throwing up) during or after coughing fits 
• Exhaustion (very tired) after coughing fits (para. 3) 
Benefits of the Vaccine 
 Before vaccinations against diphtheria, tetanus, and pertussis were available, many 
people suffered from these illnesses.  Immunizations are beneficial in protecting against these 
serious and even deadly disease processes.  The CDC (2015) reports that tetanus kills 
approximately “1 out of 10 people who are infected even after receiving the best medical care” 
(p. 1).  Prior to immunizations, diphtheria was the cause of death for tens of thousands of 
children in the United States every year (CDC, 2018).  Furthermore, the CDC (2015) reports: 
  Before vaccines, as many as 200,000 cases of diphtheria, 200,000 cases of pertussis, and 
hundreds of cases of tetanus, were reported in the United States each year. Since 
vaccination began, reports of cases for tetanus and diphtheria have dropped by about 99% 
and for pertussis by about 80%. (p. 1) 
Administration of the Vaccine 
 Vaccinations against diphtheria, tetanus, and pertussis are available in four different 
combinations: DTaP, DT, Tdap, and Td.  DTaP has an elevated level of diphtheria and pertussis 
versus the Tdap vaccine, while the DT includes more diphtheria immunization than that of the 
Td vaccine.  All variations of the vaccine are given intramuscularly in either the upper thigh or 
upper arm.   
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 According to CDC guidelines, DTaP (diphtheria, tetanus, and pertussis) is given in five 
doses.  CDC (2018) states that children receive this vaccine at the following ages:  
• 2 months 
• 4 months 
• 6 months 
• 15-18 months 
• 4-6 years 
DT (diphtheria and tetanus without the pertussis vaccine) can be given in place of the DTaP 
vaccine if someone is unable to receive the pertussis part of the immunization.  It is safe to 
administer the DTaP vaccine with other immunizations.  Often, the DTaP vaccine is part of 
combination vaccinations such as with Pentacel (combining DTaP, Hib, and IPV in one 
injection) (CDC, 2018). 
 Tdap (tetanus, diphtheria, and pertussis) is routinely given at either 11 or 12 years old 
(CDC, 2015).  Apart from school-aged children, is also important for healthcare workers, 
pregnant women (during specific trimesters), and individuals who are in close contact with 
babies younger than 12 months old to receive this vaccine as it protects the infant from pertussis 
(CDC, 2015).  Tdap or Td (tetanus and diphtheria without pertussis vaccine) are given as 
boosters every ten years. 
Risks of the Vaccine 
 It is contraindicated for individuals who are allergic to any part of the DTaP, DT, Tdap, 
and Td vaccine to receive these immunizations.  The CDC reports that only children under the 
age of 7 should receive the DTaP vaccine and children over 7 should receive Tdap due to the 
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dosing of the vaccinations (CDC, 2018).  People who should not get the diphtheria, tetanus, and 
pertussis vaccines are the following: 
• Have had a coma or experienced seizures within 7 days after being administered any 
variation of the diphtheria, tetanus, and pertussis vaccine 
• Have a history of nervous system issues or seizure disorder 
• Have Guillain-Barré Syndrome (GBS) 
• Have had severe pain and edema (swelling) after a previous dose of DTaP or DT (CDC, 
2018) 
As with any medication or vaccination, receiving these immunizations can cause adverse 
reactions.  The CDC (2018) lists common side effects of the DTaP vaccine as the following: 
• Redness, soreness, swelling, and tenderness where the shot is given are common after 
DTaP. 
• Fever, fussiness, tiredness, poor appetite, and vomiting sometimes happen 1 to 3 days 
after DTaP vaccination. 
• More serious reactions, such as seizures, non-stop crying for 3 hours or more, or high 
fever (over 105°F) after DTaP vaccination happen much less often. Rarely, the 
vaccine is followed by swelling of the entire arm or leg, especially in older children 
when they receive their fourth or fifth dose. 
• Long-term seizures, coma, lowered consciousness, or permanent brain damage 
happen extremely rarely after DTaP vaccination. (p. 2) 
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Side effects from the Tdap vaccine are similar in nature to that of those from the DTaP 
immunization.  The CDC (2015) categorizes the side effects of the Tdap vaccine as mild, 
moderate, and severe reactions.  Mild problems include pain, redness, or swelling at the injection 
site; mild fever (approximately 100.4°F); headache; fatigue (tiredness); stomach ache with or 
without nausea, vomiting, and diarrhea; chills; body aches; rash; swollen glands (CDC, 2015).  
Moderate reactions include fever greater than 102°F and swelling of the entire arm where the 
injection was given.  Severe side effects of the Tdap vaccine are severe pain, swelling, redness, 
and bleeding of the arm where the vaccine was administered; and severe allergic reactions such 
as hives, difficulty breathing (dyspnea), swelling of the face and throat, weakness, elevated heart 
rate, and dizziness (CDC, 2015). 
 In summary, the vaccinations against diphtheria, tetanus, and pertussis are combined in 
four different variations including DTaP, DT, Tdap, and Td.  DTaP and DT are intended for 
children under the age of seven years old while Tdap and Td are recommended for those over the 
age of seven.  These vaccinations protect against ailments associated with these diseases such as 
lockjaw, severe muscle tightening, dyspnea, thick coatings in the throat, paralysis, severe 
coughing spells, pneumonia, and sometimes even death just to name a few.  It is imperative for 
school-aged children to receive the immunizations (if able) as numbers have dropped drastically 
in cases of diphtheria, tetanus, and pertussis since vaccinations have been available (CDC, 2015). 
Polio Vaccine 
The Disease 
 Polio is a disease caused by a virus that is spread primarily by person-to-person contact 
(CDC, 2016).  The CDC (2016) states that polio can also be spread via the fecal-oral-route.  The 
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fecal-oral-route is when food or drinks are contaminated by feces of an infected individual and 
then consumed by an uninfected person.  The CDC (2016) reports: 
Most people infected with polio have no symptoms, and many recover without 
complications. But sometimes people who get polio develop paralysis (cannot move their 
arms or legs). Polio can result in permanent disability. Polio can also cause death, usually 
by paralyzing the muscles used for breathing. (p. 1) 
The WHO (2016) states that before the vaccination was available, polio was the leading cause 
for permanent disability in children.  The CDC states that there is no cure for polio, but that 
immunization is best for prevention of this disease (CDC, 2016). 
Benefits of the Vaccine 
 According to the CDC, polio was once very prevalent in the United States.  The CDC 
(2016) states that “it paralyzed and killed thousands of people every year before polio vaccine 
was introduced in 1955” (p. 1).  Since implementing the polio vaccine, polio has been eradicated 
from the United States.  However, some cases of polio are still active in other parts of the world 
(CDC, 2016).  The WHO (2016) reports that “all children worldwide should be fully vaccinated 
against polio, and every country should seek to achieve and maintain high levels of coverage 
with polio vaccine in support of the global commitment to eradicate polio” (p. 164).  The CDC 
(2016) adds to this statement by saying that if all countries are successful at ending polio 
worldwide, the polio vaccination will no longer be needed.   
Administration of the Vaccine 
 The polio vaccine is better known as Inactivated Polio Vaccine (IPV).  IPV is typically 
administered via the intramuscular route in either the thigh or deltoid muscles.  CDC guidelines 
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recommend that most people receive the polio vaccine at 2, 4, 6 to 18 months, and 4 to 6 years 
old (CDC, 2016).    Most adults do not need the vaccination since they are typically immunized 
as children, but the CDC (2016) states that some adults are at a higher risk of contracting the 
polio virus such as: 
• people traveling to certain parts of the world, 
• laboratory workers who might handle polio virus, and 
• health care workers treating patients who could have polio. 
These higher-risk adults may need 1 to 3 doses of IPV, depending on how many doses 
they have had in the past.  There are no known risks to getting IPV at the same time as 
other vaccines. (p. 1) 
IPV is given as both a solitary immunization and as a combination vaccine.  It is commonly 
paired with Hib and DTaP such as with Pentacel. 
Risks of the Vaccine 
 As with all medications, there are risks with the polio vaccination.  However, according 
to the CDC (2016), “IPV has not been known to cause serious problems, and most people do not 
have any problems with it” (p. 1).  Potential risks of the polio vaccination include: 
• Possible fainting or dizziness after the injection is given 
• Pain at the injection site 
• Fever 
• Severe allergic reaction such as difficulty breathing or swallowing, hives, swelling of the 
face or throat 
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People who should not receive the polio vaccine include those who are allergic to the 
immunization and those who are not feeling well.  The CDC (2016) states that anyone who has 
had a previous allergic reaction to any part of the polio vaccine should not receive it.  The CDC 
goes on to say that if a person is ill with a minor ailment such as a cold, it is permissible for them 
to receive the polio vaccination.  Contrarily, if a person has a severe illness such as the flu or a 
stomach virus, it is not recommended for that person to receive the vaccine that day (CDC, 
2016). 
In conclusion, the polio vaccine protects against the once most common form of 
childhood paralysis.  It is administered primarily to children, but can be given to adults under 
certain circumstances.  The most important benefit of the polio vaccine is that it has completely 
eliminated the polio virus in the United States and in other parts of the world, as well.  Risks of 
the vaccination are minimal, and efforts to eradicate this disease worldwide are made possible by 
vaccination. 
Pneumococcal Conjugate Vaccine 
The Disease 
 Pneumococcal disease is caused by the bacteria Streptococcus pneumoniae and is spread 
by close contact with an infected person (CDC, 2017).  According to the CDC, it can lead to 
simple ailments such as ear infections and can also cause severe complications such as 
pneumonia (infection of the lungs), bacteremia (infection of the blood), and meningitis (infection 
covering the brain and spinal cord) (CDC, 2015).   
 Anyone is susceptible to contracting the pneumococcal disease, but it is most prevalent in 
children less than the age of 2 and adults over the age of 65 (CDC, 2015).  The CDC (2015) goes 
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on to say that “people with certain medical conditions, and cigarette smokers” are also at a 
higher risk for pneumococcal disease (p. 1).  The CDC (2015) reports that “pneumococcal 
pneumonia is most common among adults. Pneumococcal meningitis can cause deafness and 
brain damage, and it kills about 1 child in 10 who get it” (p. 1). 
 Clinical diagnosis of pneumococcal disease can vary.  It is typically verified via 
laboratory findings.  Meningitis is confirmed via cerebrospinal fluid while bacteremia is 
confirmed by blood specimens (CDC, 2017).  These tests are crucial in determining what type of 
antibiotic treatment is appropriate as some pneumococcal diseases are resistant to certain 
antibiotics (CDC, 2017). 
Benefits of the Vaccine 
 The Pneumococcal Conjugate Vaccine (also known as PCV13 and Prevnar13®) protects 
against 13 different pneumococcal bacteria (CDC, 2017).  The CDC (2015) reports: 
Before there was a vaccine, the United States saw: 
• more than 700 cases of meningitis, 
• about 13,000 blood infections, 
• about 5 million ear infections, and 
• about 200 deaths 
in children under five each year from pneumococcal disease. Since the vaccine became 
available, severe pneumococcal disease in these children has fallen by 88%. (p. 1) 
Administration of the Vaccine 
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 The pneumococcal vaccine is administered via the intramuscular route in either the upper 
thigh or deltoid muscle.  The CDC (2015) recommends that children receive this vaccine at two, 
four, six, and 12-15 months of age.  The CDC (2015) also states that the immunization should be 
given to “children and adults two to 64 years of age with certain health conditions, and for all 
adults 65 years of age and older” (p. 1). 
Risks of the Vaccine 
 Risks related to the pneumococcal vaccine include both mild and serious reactions.  
According to the CDC (2015) reactions to this immunization may vary by age and with the dose 
in the series.  In relations to school-aged children, the most common problems reported by the 
CDC (2015) were the following: 
• About half became drowsy after the shot, had a temporary loss of appetite, or had redness 
or tenderness where the shot was given. 
• About 1 out of 3 had swelling where the shot was given. 
• About 1 out of 3 had a mild fever, and about 1 in 20 had a fever over 102.2°F. 
• Up to about 8 out of 10 became fussy or irritable. (p. 1) 
Other common reactions to the vaccine include pain, swelling, and redness at the injection site; 
along with muscle pain, mild fever, headache, chills, and fatigue (CDC, 2015).  More serious 
reactions include difficulty breathing, swelling of the face or throat, elevated heart rate, and 
hives.  These symptoms indicate a possible severe allergic reaction. 
 The pneumococcal vaccination is contraindicated for several people.  Those who have 
had a serious allergic reaction to the pneumococcal vaccine should not receive it (CDC, 2015).  
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Furthermore, anyone that has had a life-threatening reaction to any vaccine containing diphtheria 
toxoid (such as DTaP) should also avoid the pneumococcal immunization as it contains a variant 
of the diphtheria toxin (CDC, 2015).  It is also reported that if the person receiving the 
vaccination is ill, the provider may decide to give the shot on a different day since the 
immunization could potentially worsen their symptoms (CDC, 2015). 
 All in all, the pneumococcal vaccination is effective at helping prevent infections such as 
ear infections, pneumonia, bacteremia, and meningitis.  It is most commonly administered to 
infants between the ages of two months and 15 months, but is also given to persons between the 
ages of two and 65 years old.  Benefits of the vaccine are greater than the mild side effects that 
one may receive, but the immunization should be avoided if there is a history of reaction to 
previous doses or if a person is allergic to any component of the pneumococcal vaccine. 
Rotavirus 
The Disease 
 According to the CDC (2018) the rotavirus is a viral infection which causes diarrhea, 
vomiting, and fever mostly in babies and young children.  The WHO (2013) reports that the 
rotavirus typically has an incubation period of one to three days and is followed by an abrupt 
onset of vomiting, fever, and explosive watery diarrhea.  “Transmission occurs primarily by the 
[fecal]-oral route directly from person to person, or indirectly via contaminated fomites” (WHO, 
2013, p. 51).  A fomite is defined as “objects such as clothing, towels, and utensils that may 
harbor a disease agent and are capable of transmitting it” (Lippincott, Williams, and Wilkins, 
2005, p. 560).   
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 The rotavirus is positively diagnosed in a laboratory setting via stool specimens (CDC, 
2018).  Currently, there is no cure against the rotavirus (WHO, 2013).  Treatment commonly 
focuses on preventing dehydration by use of fluid replacement either orally or intravenously. 
Benefits of the Vaccine 
The CDC (2018) states that before the rotavirus vaccine was available, “almost all 
children in the United States had at least one rotavirus infection before their fifth birthday” (p. 1).  
The CDC (2018) also reports the following: 
Every year before the vaccine was available: 
• more than 400,000 young children had to see a doctor for illness caused by rotavirus, 
• more than 200,000 had to go to the emergency room, 
• 55,000 to 70,000 had to be hospitalized, and 
• 20 to 60 died. 
Since the introduction of the rotavirus vaccine, hospitalizations and emergency visits for 
rotavirus have dropped dramatically. (p. 1) 
In addition to those statistics, the rotavirus vaccine protects almost all babies from severe 
rotavirus diarrhea.  This does not mean that children are safe from all diarrhea.  They are only 
protected against diarrhea caused by the rotavirus.  
Administration of the Vaccine 
 The rotavirus vaccine is one of the only vaccines administered via the oral route.  It is a 
liquid vaccine that is routinely given in either two or three doses depending on which brand of 
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vaccine is used.  The CDC recommends that the immunization be given at the following 
intervals:  
• First Dose: two months old 
• Second Dose: 4 months old 
• Third Dose: 6 months old (if needed) 
The CDC (2018) goes on to say that the first dose must be given “before 15 weeks of age, and 
the last by age eight months.  Rotavirus vaccine may safely be given at the same time as other 
vaccines” (p. 1). 
Risks of the Vaccine 
 Even though the rotavirus vaccination is administered differently than those vaccines 
aforementioned, some side effects are still possible when receiving this immunization.  Most 
reactions to the rotavirus are mild and go away on their own.  Serious reactions are possible, but 
rare (CDC, 2018).  According to the CDC (2018) mild side effects include irritability, or mild, 
temporary diarrhea or vomiting in babies.  More serious side effects include intussusception and 
severe allergic reactions.  Intussusception is a bowel blockage and is defined in Stedman’s 
Medical Dictionary as “the taking up or receiving of one part within another, especially the 
enfolding of one segment of the intestine within another” (Lippincott et al., 2005, p. 769). 
 Furthermore, some children should avoid the rotavirus vaccination completely.  These 
children include the following: 
• Those with life-threatening allergic reactions to any part of the rotavirus vaccine 
or to a previous dose of the rotavirus immunization 
• Those who have a severe latex allergy 
IMMUNIZATIONS IN SCHOOL-AGED CHILDREN  26 
 
   
 
• Children with severe combined immunodeficiency (SCID) 
• Babies who have intussusception  
• Babies who are moderately or severely ill (including those with diarrhea and/or 
vomiting) 
• Those with a weakened immune system (for example- HIV/AIDS, cancer, 
treatment with steroids)  (CDC, 2018) 
In conclusion, the rotavirus vaccine aids in protecting against one of the most common 
causes of gastrointestinal upset in babies, the rotavirus.  Benefits of the vaccine include 
decreased severity of diarrhea if a vaccinated individual were to contract the rotavirus or 
complete immunity against the virus.  Receiving the rotavirus vaccination can ultimately protect 
against dehydration most commonly caused by the rotavirus.  This liquid oral immunization is 
recommended for babies in two to three doses between the ages of two months and 6 months of 
age.  Benefits of the vaccine typically outweigh the risks as side effects are typically mild and 
serious reactions are rare in nature.   
Measles, Mumps, and Rubella (MMR) Vaccine 
The Diseases 
 Measles is a viral infection that is characterized by fever, nasal drainage, cough, red, 
watery eyes, and is most commonly followed by a systemic rash (a rash covering the entire 
body).  The CDC (2018) states that measles “can lead to ear infections, diarrhea, and infection of 
the lungs (pneumonia).  Rarely, measles can cause brain damage or death” (p. 1).  It is reported 
that the measles rash consists of multiple flat red bumps that typically start on the head and face 
and spread downward toward the trunk and lower limbs (CDC, 2018).  Tiny white lesions called 
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Koplik spots can also appear in the mouth of an infected person as an early sign of the measles 
virus (CDC, 2018).   
 In regards to transmission, the measles virus is spread by airborne particles.  On their 
website, the CDC (2018) reports: 
Measles is a highly contagious virus that lives in the nose and throat mucus of an infected 
person. It can spread to others through coughing and sneezing. Also, measles virus can 
live for up to two hours in an airspace where the infected person coughed or sneezed. If 
other people breathe the contaminated air or touch the infected surface, then touch their 
eyes, noses, or mouths, they can become infected. Measles is so contagious that if one 
person has it, 90% of the people close to that person who are not immune will also 
become infected. (para. 1) 
 Mumps is a virus that symptoms include headaches, fever, body aches, decreased 
appetite, fatigue, and swollen and tender salivary glands including one or both sides (CDC, 
2018).  In relation to the mumps virus, the CDC (2017) states: 
It spreads through saliva or mucus from the mouth, nose, or throat. An infected person 
can spread the virus by 
• coughing, sneezing, or talking, 
• sharing items, such as cups or eating utensils, with others, and 
• touching objects or surfaces with unwashed hands that are then touched by others. 
Mumps likely spreads before the salivary glands begin to swell and up to five days after 
the swelling begins. (para. 1) 
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 Mumps can ultimately be a very debilitating disease.  It can lead to deafness, encephalitis 
or meningitis (swelling of the brain and/or spinal cord covering).  Mumps can also result in 
“painful swelling of the testicles or ovaries and, very rarely, death” (CDC, 2018, p. 1). 
 Rubella is viral infection that is also known as German Measles.  Rubella is spread from 
person to person by contact with nasal or throat secretions or by contact with droplets in the air 
from an infected person sneezing or coughing (CDC, 2018).  Common signs and symptoms of 
rubella include: 
• fever, sore throat, eye irritations, headaches, and rash 
• arthritis in teenagers and adult women 
• possible miscarriage or serious birth defects if a pregnant woman is infected (CDC, 2018) 
The CDC (2018) reports that since the introduction of the MMR vaccination, these diseases are 
much less common in the United States. 
Benefits of the Vaccine 
 The MMR vaccination has many benefits, one of which is that after receiving the 
recommended dosages of the vaccine, individuals are protected against three different life-
altering and life-threatening diseases.  Statistics show that the MMR has proven to be effective in 
preventing these illnesses.  The CDC (2018) reports: 
One dose 
• One dose of MMR vaccine is— 
o 93% effective for measles (range: 39%–100%) 
o 78% effective for mumps (range: 49%−92%) 
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o 97% effective for rubella (range: 94%–100%) 
Two doses 
• Two doses of MMR are— 
o 97% effective for measles (range: 67%–100%) 
o 88% effective for mumps (range: 31%–95%) (para. 3) 
Equally as important, the CDC (2018) states that “people who receive MMR vaccination 
according to the U.S. vaccination schedule are considered protected for life” (para. 4). 
Administration of the Vaccine 
 The MMR vaccine is an injectable immunization that is most commonly administered via 
the intramuscular route in either the upper thigh or deltoid muscle.  The CDC (2018) 
recommends that this immunization be given in two doses.   
• First dose between 12 to 15 months old 
• Second dose between the ages of four and six years old 
It is also recommended that any infant between the ages of six and 11 months old should receive 
a dose of the MMR vaccine if they will be traveling outside of the United States as it can provide 
temporary protection against a measles infection (CDC, 2018).   
 Furthermore, the MMR vaccine can be administered as a third dose during certain 
situations such as a mumps outbreak (CDC, 2018).  The CDC (2018) also states that there are no 
known risks to receiving the MMR vaccine at the same time as other immunizations.  The MMR 
vaccine is sometimes given as a combination vaccine known as the MMRV.  This vaccination 
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includes not only immunity from measles, mumps, and rubella, but also varicella (also known as 
chickenpox). 
Risks of the Vaccine 
 In comparison to other immunizations, the MMR vaccine can be more risky to certain 
populations.  The CDC states the MMR vaccine should be avoided by: 
• Anyone with a severe or life-threatening allergy to any part of the MMR vaccine 
• Any woman who is pregnant or plans to be pregnant within a month from receiving the 
MMR vaccine 
• Any person with a weakened immune system related to a disease process such as 
HIV/AIDS, or is receiving medical treatments such as chemotherapy or radiation 
• Anyone with a parent or sibling with a history of being immunocompromised 
• Anyone with a history of bruising or bleeding conditions 
• Anyone who has received blood products or has undergone a recent blood transfusion 
• Any person with active tuberculosis 
• Any individual that has received any live vaccinations within the past four weeks 
• Anyone who is suffering from a moderate or severe illness (CDC, 2018) 
As with other vaccinations and medications, certain side effects can be associated with 
the MMR vaccine.  Minor reactions to the immunization can include fever, pain or redness at the 
injection site, or swelling of the gland in the cheeks or neck (CDC, 2018).  Moderate side effects 
can include a systemic rash, temporary low platelet count (which can cause easy bruising or 
bleeding), seizures, and temporary joint pain and stiffness (CDC, 2018).  More serious reactions 
to the MMR vaccine include potential brain damage, deafness, long-term seizures, or a coma 
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(CDC, 2018).  The CDC (2018) states that “most people who get MMR vaccine do not have any 
problems with it” (p. 2). 
In summary, the MMR vaccine protects against three different, harmful viruses: measles, 
mumps, and rubella.  These diseases can lead to a plethora of symptoms that range in seriousness 
from fevers and rashes all the way to brain damage or even death.  Life-time immunization can 
be provided by receiving the MMR vaccine in the two doses recommended by the CDC.  When 
comparing the pros and cons of the MMR immunization, the CDC (2018) states that “getting the 
MMR vaccine is much safer than getting measles, mumps, or rubella disease” (p. 2). 
Varicella Vaccine 
The Disease 
 Varicella (also known as chickenpox) is caused by the varicella zoster virus (CDC, 
2018).  According to the CDC (2018), the varicella virus is “usually mild, but it can be serious in 
infants under 12 months of age, adolescents, adults, pregnant women, and people with weakened 
immune systems” (p. 1).  Chickenpox is spread via close contact with an infected person (CDC, 
2018).  Chickenpox can also be contracted from an individual with shingles- a rash caused by the 
same varicella zoster virus (CDC, 2018).   
 Varicella causes an itchy rash all over the body that typically last around one week (CDC, 
2018).  The CDC (2018) also states that the chickenpox virus can also cause: 
• fever 
• tiredness 
• loss of appetite 
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• headache 
More serious complications can include: 
• skin infections 
• infection of the lungs (pneumonia) 
• inflammation of blood vessels 
• swelling of the brain and/or spinal cord coverings (encephalitis or meningitis) 
• blood stream, bone, or joint infections 
Some people get so sick that they need to be hospitalized. It doesn’t happen often, but 
people can die from chickenpox (p. 1) 
Benefits of the Vaccine 
 “Chickenpox vaccine became available in the United States in 1995” (CDC, 2018, para. 
3).  Before the vaccine was readily available, an average of four million people each year in the 
United States got chickenpox, 10,500 to 13,000 were hospitalized, and approximately 100 to 150 
died each year (CDC, 2018).  The CDC (2018) states that “each year, more than 3.5 million 
cases of chickenpox, 9,000 hospitalizations, and 100 deaths are prevented by chickenpox 
vaccination in the United States” (para. 3). 
 Some vaccinated people can still contract chickenpox.  However, for these people, 
symptoms are usually milder with fewer or no blisters at all (CDC, 2018). The CDC goes on to 
say the following: 
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Two doses of the chickenpox vaccine is more than 90% effective at preventing 
chickenpox. When [a person] get[s] vaccinated, [that individual] protect[s] [themselves] 
and others in [their] family and community. This protection is especially important for 
people who cannot get vaccinated, such as those with weakened immune systems, or 
pregnant women. (para. 2) 
Administration of the Vaccine 
 Varicella vaccine is an injectable vaccine that is administered via the subcutaneous route 
typically in the upper arm or upper thigh.  The chickenpox vaccine is recommended for children 
between the ages of 12 months and 12 years old (CDC, 2018).  The CDC recommends that the 
vaccine be given in two doses as follows: 
• First dose: between 12 and 15 months old 
• Second dose: between the ages of four to six years old 
In addition, it is safe to receive the varicella vaccine at the same time as other 
vaccinations.  It is most commonly paired with the MMR vaccine (also known as the MMRV).  
Furthermore, the CDC (2018) states the following: 
People 13 years of age or older who didn’t get the vaccine when they were younger, and 
have never had chickenpox, should get two doses at least 28 days apart. A person who 
previously received only one dose of chickenpox vaccine should receive a second dose to 
complete the series.  The second dose should be given at least 3 months after the first 
dose for those younger than 13 years, and at least 28 days after the first dose for those 13 
years of age or older. (p. 1) 
Risks of the Vaccine 
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 Risks of the varicella vaccine include both minor and more serious side effects.  
However, “most people who get chickenpox vaccine do not have any problems with it” (CDC, 
2018).  Minor events include: 
• Redness or soreness at the injection site 
• Fever 
More serious events include: 




The CDC (2018) reports that sometimes a rash can develop following varicella vaccination.  
Individuals that develop this rash are capable of spreading the varicella vaccine virus to 
unprotected people.  The CDC (2018) states that “even though this happens very rarely, anyone 
who gets a rash should stay away from people with weakened immune systems and unvaccinated 
infants until the rash goes away” (p. 2). 
 People with known allergies to any part of the varicella vaccine or those who have had a 
serious life-threatening reaction to any previous dose should avoid this vaccine.  The CDC 
(2018) reports that other individuals who should refrain from getting the varicella vaccine 
include the following: 
• Pregnant women, or those that may be pregnant 
• Individuals with weakened immune systems 
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• People with a parent or sibling with a history of immune system issues 
• Those taking salicylates (for example: aspirin) 
• Individuals who have received blood or blood product transfusions 
• Those with active tuberculosis 
• People that have received other live vaccinations within the past four weeks 
• Individuals who are not feeling well (CDC, 2018) 
The CDC (2018) states that it is permissible for someone with an acute illness such as a common 
cold to receive the varicella vaccine, but those with more serious ailments should avoid the 
vaccine until advised by their medical provider. 
 In conclusion, varicella is a contagious disease caused by the varicella zoster virus and is 
most commonly referred to as the chickenpox virus.  Benefits of the vaccine greatly outweigh the 
risks of the vaccine with statistical data showing that since the introduction of the vaccine in 
1995, the number of cases of chickenpox has decreased by millions.  Although there are some 
potential side effects of the vaccine, reactions are “usually mild and go away on their own” 
(CDC, 2018, p. 2). 
Hepatitis A Vaccine 
The Disease 
 According to the CDC (2016), “Hepatitis A is a serious liver disease.  It is caused by the 
hepatitis A virus (HAV)” (p. 1).  Hepatitis A is spread via the fecal-oral route either by person to 
person contact or via a fomite contaminated with infected feces such as food or water (CDC, 
2017).  Typically, contamination is a result of poor hand hygiene.  The CDC (2017) states that 
hepatitis A “is a self-limited disease that does not result in chronic infection” (para. 1). 
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 According to the CDC (2016), most children do not experience symptoms of hepatitis A, 
however, majority of adults do.   The CDC reports that the hepatitis A virus can still be spread 
even with the absence of symptoms.  Typical signs and symptoms of hepatitis A infection 
include: 
• Jaundice (yellowing of the eyes or skin, dark urine, clay-colored feces) 
• Fever, fatigue, nausea, vomiting, joint pain, decreased appetite 
• Diarrhea and severe stomach pains (CDC, 2016) 
WHO (2012) states that diagnosis of hepatitis A is confirmed in the lab via serological 
testing.  The CDC (2016) reports that symptoms of hepatitis A typically appear between two and 
six weeks after exposure to the virus and “usually last less than two months, although some 
people can be ill for as long as six months” (p. 1).  The CDC (2016) goes on to say that  
“hepatitis A can cause liver failure and death, although this is rare and occurs more commonly in 
persons 50 years of age or older and persons with other liver diseases, such as hepatitis B or C” 
(p. 1). 
Benefits of the Vaccine 
 Although the exact length of protection is unknown, the CDC (2019) states that the 
hepatitis A vaccine lasts for at least 20 years in both children and adults.  The CDC (2019) goes 
on to say that “hepatitis A rates in the United States have declined by more than 95% since 
hepatitis A vaccine first became available in 1995” (para. 1).  Furthermore, the hepatitis A 
vaccine is safe to administer with other vaccinations with no complications (CDC, 2019).  The 
CDC (2019) reports that “hepatitis B, diphtheria, poliovirus (oral and inactivated), tetanus, 
typhoid (oral and intramuscular), cholera, Japanese encephalitis, rabies, and yellow fever 
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vaccines can be given at the same time that hepatitis A vaccine is given, but at a different 
injection site” (para. 32). 
Administration of the Vaccine 
 The hepatitis A vaccination is an injectable, inactivated vaccine that is administered via 
the intramuscular route in either the deltoid or upper thigh.  For long-lasting protection, it is 
recommended that everyone receive two doses of the hepatitis immunization at least 6 month 
apart (CDC, 2016).  It is most common for children to receive their first dose of the hepatitis 
vaccine “between their first and second birthdays (12-23 months of age)” (CDC, 2016, p. 1).   
Aside from the recommended doses for children, other populations should consider 
receiving the hepatitis A vaccine.  According to the CDC (2016), people that should receive the 
hepatitis A vaccine also include those who: 
• are traveling to countries where hepatitis A is common, 
• are a man who has sex with other men, 
• use illegal drugs, 
• have a chronic liver disease such as hepatitis B or hepatitis C, 
• are being treated with clotting-factor concentrates, 
• work with hepatitis A-infected animals or in a hepatitis A research laboratory, or 
• expect to have close personal contact with an international adoptee from a country where 
hepatitis A is common (p. 1) 
The CDC (2019) reports the following:  
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The hepatitis A vaccine also comes in a combination form, containing both hepatitis A 
and B vaccine, that can be given to anyone 18 years of age and older. This combination 
vaccine is given as three shots, over six months. All three shots are needed for long-term 
protection for both hepatitis A and B. (para. 22) 
Risks of the Vaccination 
 As with any medication or vaccination, there are risks to receiving the hepatitis A 
vaccine.  Minor side effects include but are not limited to: 
• redness or soreness at the injection site 
• low grade fever 
• tiredness 
• headache 
More serious reactions can include allergic reactions involving “hives, swelling of the face and 
throat, difficulty breathing, a fast heartbeat, dizziness, and weakness. These would usually start a 
few minutes to a few hours after the vaccination” (CDC, 2016, p. 2). 
 The CDC (2016) states that if there is a known allergic reaction to any part of the 
hepatitis A vaccine, it should be avoided.  Furthermore, individuals who are ill should not 
receive the hepatitis A immunization.  However, if the illness is only a minor cold, it is most 
likely safe to receive the vaccine with no issues (CDC, 2016). 
 In conclusion, the hepatitis A vaccine protects against the viral liver disease known as 
hepatitis A.  Hepatitis A can result in fever, jaundice, joint pain, nausea, vomiting, diarrhea, clay-
colored stools, dark urine, and yellowing of the skin and eyes.  In severe cases, hepatitis A can 
cause liver failure and death.  Immunization is recommended for children between the ages of 
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one and two but can also be administered to adults in certain situations.  Vaccination of hepatitis 
A have proven to be beneficial as numbers of confirmed cases have decreased drastically since 
the vaccine was introduced in 1995.  Benefits of the hepatitis A vaccine greatly outweigh the 
minimal risks associated with the immunization. 
Meningococcal ACWY Vaccine 
The Disease 
 Meningococcal disease is a bacterial infection caused by the bacteria called Neisseria 
meningitidis (CDC, 2018).  The CDC (2018) reports that this bacteria “can lead to meningitis 
(infection of the lining of the brain and spinal cord) and infections of the blood. Meningococcal 
disease often occurs without warning – even among people who are otherwise healthy” (p. 1).  
“There are at least 12 types of N. meningitidis, called ‘serogroups.’  Serogroups A, B, C, W, and 
Y cause most meningococcal disease” (CDC, 2018, p. 1). 
 Meningococcal disease is spread via person-to-person contact through close or lengthy 
contact.  Close contact refers to kissing or coughing while lengthy contact is associated with long 
exposure to an infected person such as living in the same household (CDC, 2018).  The CDC 
(2017) reports that “people do not catch [N. meningitidis] through casual contact or by breathing 
air where someone with meningococcal disease has been” (para. 3).  It is possible for an 
individual to be a carrier of the N. meningitidis bacteria but not become infected with it (CDC, 
2017).  “About 1 in 10 people have these bacteria in the back of their nose and throat with no 
signs or symptoms of disease” (CDC, 2017, para. 1).   
 In regard to susceptibility to contracting the meningococcal disease, the CDC (2018) 
reports the following: 
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Anyone can get meningococcal disease but certain people are at increased risk, including: 
• Infants younger than one year old 
• Adolescents and young adults 16 through 23 years old 
• People with certain medical conditions that affect the immune system 
• Microbiologists who routinely work with isolates of N. meningitidis 
• People at risk because of an outbreak in their community (p. 1) 
According to the CDC (2018), the meningococcal disease kills 10-15 out of 100 infected 
people even after treatment.  Those who survive meningococcal disease can suffer debilitating 
complications.  These issues can include brain damage, kidney damage, hearing loss, 
amputations, nervous system issues, and scars related to skin grafts (CDC, 2018). 
Benefits of the Vaccine 
 The CDC (2018) reports that the “Meningococcal ACWY vaccine can help prevent 
meningococcal disease caused by serogroups A, C, W, and Y.  A different meningococcal 
vaccine is available to help protect against serogroup B” (p. 1).  The CDC (2019) goes on to say 
that “teens and young adults are at increased risk for meningococcal disease. Meningococcal 
disease is a very serious illness where death can occur in as little as a few hours” (para. 1).  The 
meningococcal ACWY vaccine can help protect children and also adults against this potentially 
deadly disease. 
Administration of the Vaccine 
 The meningococcal ACWY vaccine is an injectable vaccine that is typically administered 
intramuscularly in the deltoid muscle.  School-aged children between the ages of 11 through 18 
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are recommended to receive two doses of the meningococcal ACWY vaccine.  The doses should 
be administered as follows: 
• First dose:  at 11 or 12 years old 
• Second dose: at age 16 
“Some adolescents including those with HIV, should get additional doses” (CDC, 2018, 
p. 1).  The CDC (2018) also states the following: 
In addition to routine vaccination for adolescents, MenACWY vaccine is also 
recommended for certain groups of people: 
• People at risk because of a serogroup A, C, W, or Y meningococcal disease outbreak 
• People with HIV 
• Anyone whose spleen is damaged or has been removed, including people with sickle cell 
disease 
• Anyone with a rare immune system condition called “persistent complement component 
deficiency” 
• Anyone taking a drug called eculizumab (also called Soliris®) 
• Microbiologists who routinely work with isolates of  N. meningitidis 
• Anyone traveling to, or living in, a part of the world where meningococcal disease is 
common, such as parts of Africa 
• College freshmen living in dormitories 
• U.S. military recruits 
IMMUNIZATIONS IN SCHOOL-AGED CHILDREN  42 
 
   
 
Some people need multiple doses for adequate protection. (p. 1) 
The meningococcal ACWY vaccine is safe to administer at the same time as other 
immunizations. 
Risks of the Vaccination 
 Most all medications and vaccines come with risks, and the meningococcal ACWY 
vaccine is no different.  The majority of side effects associated with the meningococcal ACWY 
vaccine are “mild and go away on their own within a few days, but serious reactions are also 
possible” (CDC, 2018, p. 1).  The CDC (2018) states that minor reactions can include the 
following: 
• Redness or pain at the injection site 
• Fever 
More severe reactions may include allergic reactions to any part of the meningococcal vaccine, 
or severe pain in the arm that the injection was given (CDC, 2018). 
 The CDC (2018) reports that people who should avoid the meningococcal ACWY 
vaccine are those who: 
• Have had a severe or life-threatening allergic reaction to a previous dose of the 
meningococcal ACWY vaccine or a severe reaction to any component of the vaccine 
• Are moderately or severely ill 
Not much is known about the risks of this vaccine for a pregnant woman or breastfeeding 
mother.  However, pregnancy or breastfeeding are not reasons to avoid MenACWY 
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vaccination. A pregnant or breastfeeding woman should be vaccinated if she is at 
increased risk of meningococcal disease. (CDC, 2018, p. 2) 
 In summary, the meningococcal ACWY vaccination protects against a bacteria called 
Neisseria meningitidis.  This bacteria can lead to the serious, and sometimes fatal, illness 
meningitis.  It is spread by person-to-person contact but can potentially be prevented by 
receiving the recommended two doses of the meningococcal ACWY vaccine between the ages of 
11 to 18.  Benefits outweigh the minimal risks associated with the meningococcal vaccine and 
therefore is a vaccine recommended for all school-aged children (CDC, 2018). 
Influenza Vaccine 
The Disease 
 Influenza, also known as the “flu” is a “contagious disease that spreads around the United 
States every year, usually between October and May” (CDC, 2015, p. 1).  The flu is caused by 
the influenza virus and is spread via droplets.  The CDC (2018) reports the following: 
People with flu can spread it to others up to about six feet away. Most experts think that 
flu viruses spread mainly by droplets made when people with flu cough, sneeze or talk. 
These droplets can land in the mouths or noses of people who are nearby or possibly be 
inhaled into the lungs. Less often, a person might get flu by touching a surface or object 
that has flu virus on it and then touching their own mouth, nose, or possibly their eyes. 
(para. 1) 
 According to the CDC (2015), anyone is susceptible to catching the influenza virus.  
Symptoms, however, can vary by age and can last for several days.  Some of these symptoms 
include: 
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• Myalgias (muscle aches) 
• Sore throat 
• Nasal congestion or drainage 
• Fatigue 
Influenza is more dangerous for “infants and young children, people 65 years of age and 
older, pregnant women, and people with certain health conditions or a weakened immune 
system” (CDC, 2015, p. 1).  Aside from the symptoms experienced during an active case of the 
influenza virus, the flu can also lead to complications such as pneumonia, blood infections, 
seizures, and diarrhea (CDC, 2015).  The CDC (2015) states that if a person suffers from “a 
medical condition, such as heart or lung disease, flu can make it worse” (p. 1).  Symptoms of the 
flu can be treated with anti-viral medications, but the best way to prevent influenza is by 
immunization. 
Benefits of the Vaccine 
 The influenza virus causes thousands of fatalities in the United States each year and even 
more hospitalizations (CDC, 2015).  The CDC (2015) reports that the “flu vaccine can: 
• keep you from getting flu, 
• make flu less severe if you do get it, and 
• keep you from spreading flu to your family and other people” (p. 1). 
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The flu immunization has also been reported to help protect women during pregnancy and 
postpartum as well as “significantly reduce a child’s risk of dying from influenza” (CDC, 2019, 
para. 6). 
 In addition, the CDC (2019) also reports the following beneficial statistics regarding the 
flu vaccine: 
• Flu vaccination can reduce the risk of flu-associated hospitalization for children, working 
age adults, and older adults. 
• Flu vaccine prevents tens of thousands of hospitalizations each year. For example, 
during 2016-2017, flu vaccination prevented an estimated 85,000 flu-related 
hospitalizations. 
• A 2014 study showed that flu vaccine reduced children’s risk of flu-related pediatric 
intensive care unit (PICU) admission by 74% during flu seasons from 2010-2012. 
• In recent years, flu vaccines have reduced the risk of flu-associated hospitalizations 
among adults on average by about 40%. 
• A 2018 study showed that from 2012 to 2015, flu vaccination among adults reduced the 
risk of being admitted to an intensive care unit (ICU) with flu by 82 percent (para. 3) 
Administration of the Vaccine 
 The influenza vaccine is recommended every year to people six months old and above 
prior to “flu season” (approximately between the months of October and May).  The flu vaccine 
is administered intramuscularly in either the deltoid muscle or the upper thigh, depending on age.  
Most people are only recommended to receive one dose of the vaccine, however, children 
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between the ages of six months to eight years old by need two doses during the same flu season 
(CDC, 2015).  
 One common misconception regarding the influenza vaccine is that “it causes the flu”.  
Contrarily, the CDC (2015) reports “there is no live flu virus in the flu shots.  They cannot cause 
the flu” (p. 1).   
Risks of the Vaccine 
 Since there are numerous influenza viruses that are ever-changing, the flu vaccine is also 
changing yearly to protect against the most likely strands of the flu to cause disease that 
upcoming season (CDC, 2015).  With that being said, the flu vaccine can only protect against 
three or four different influenza viruses each year.  There is no guarantee that the vaccine will 
protect against the strand of flu that is most prevalent that flu season.   
 Moreover, the CDC (2015) states that the influenza vaccine cannot protect against 
illnesses that look like the flu.  Minor side effects of the influenza vaccine can include the 
following: 
• “soreness, redness, or swelling where the shot was given 
• hoarseness 
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• fatigue” (p. 2). 
The CDC (2015) reports that more severe reactions to the influenza vaccine are possible and can 
potentially include: 
• There may be a small increased risk of Guillain-Barré Syndrome (GBS) after inactivated 
flu vaccine. This risk has been estimated at 1 or 2 additional cases per million people 
vaccinated. This is much lower than the risk of severe complications from flu, which can 
be prevented by flu vaccine. 
• Young children who get the flu shot along with pneumococcal vaccine (PCV13), and/or 
DTaP vaccine at the same time might be slightly more likely to have a seizure caused by 
fever. Ask your doctor for more information. Tell your doctor if a child who is getting flu 
vaccine has ever had a seizure. (p. 2) 
In addition, a few certain populations should avoid the influenza vaccine altogether.  
These people include those who: 
• have an egg allergy 
• have any severe or life-threatening reaction to any part of the flu vaccine 
• have ever had Guillain-Barré syndrome 
• have a moderate to severe illness at the time of vaccination (CDC, 2015) 
In conclusion, the influenza vaccine protects against the influenza virus.  This virus can 
lead to several complications including but not limited to pneumonia, blood infections, seizures, 
and even death.  Although controversial, the benefits of the flu vaccine outweigh the risks of the 
vaccine in that even if a person contracts the virus following immunization, symptoms can be 
greatly reduced in severity by receiving the vaccine (CDC, 2015). 
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Human Papillomavirus Vaccine (HPV Vaccine) 
The Disease 
 The human papillomavirus is a viral disease associated with many types of cancers 
including:  
• “cervical cancer in females 
• vaginal and vulvar cancers in females 
• anal cancer in females and males 
• throat cancer in females and males, and 
• penile cancer in males” (CDC, 2016, p. 1). 
The CDC (2016) goes on to say the following: 
HPV infection usually comes from sexual contact, and most people will become infected 
at some point in their life. About 14 million Americans, including teens, get infected 
every year. Most infections will go away on their own and not cause serious problems. 
But thousands of women and men get cancer and other diseases from HPV. (CDC, 2016, 
p. 1) 
Benefits of the Vaccine 
 In addition to protecting against the aforementioned type of cancers, the HPV vaccine 
also aids in preventing infection with HPV types that cause genital warts in both males and 
females (CDC, 2016).  The CDC (2016) states that “in the U.S., about 12,000 women get 
cervical cancer every year, and about 4,000 women die from it. HPV vaccine can prevent most 
of these cases of cervical cancer” (p. 1).   
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Administration of the Vaccine 
 The HPV vaccine is an injectable immunization typically administered in the deltoid 
muscle.  It is recommended by the CDC that both males and females receive this vaccine (CDC, 
2016).  The HPV vaccine can be given to people between the ages of nine and 26 years old.  The 
CDC (2016) states that children between nine and 14 years old should receive the vaccine in a 
two-dose series with six to 12 months between the two doses.  However, if the vaccine is not 
initiated until age 15, the vaccine should be administered “as a three-dose series with the second 
dose given 1-2 months after the first dose and the third dose given 6 months after the first dose” 
(CDC, 2016, p. 1).  
Risks of the Vaccine 
 According to the CDC (2016), “most people who receive the HPV vaccine do not have 
any serious problems with it” (p. 1).  Side effects are typically mild and subside on their own 
(CDC, 2016).  The most common side effects of the HPV vaccine are minor and can include the 
following: 
• redness and/or pain at the injection site 
• fever 
• headache 
Furthermore, the CDC (2016) reports that certain people should avoid receiving the HPV 
vaccine altogether.  These people include: 
• Anyone who has had a reaction to any component of the HPV vaccine 
• Any woman who is pregnant 
• Anyone who is suffering from a mild or moderate illness 
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In conclusion, the HPV vaccine aids in preventing infection with the human 
papillomavirus related to several (but not all) types of cancers.  The HPV vaccine is injectable 
and is administered to school-aged children and adults in either a two or a three dose series, 
depending on the age of the recipient.  Benefits of the HPV vaccine outweigh the risks of the 
immunization as side effects are minimal. 
Conclusion 
 In summary, when contemplating whether parents/caregivers wish to immunize their 
children or not, it is imperative that they utilize all of the information that is available to them.  
Vaccines are important for all individuals, but are especially critical to the school-aged 
population.  Since so many of the aforementioned 16 diseases require immunization either as an 
infant or during childhood, decisions to vaccinate must be made in a timely manner.  As stated 
previously, the choice to vaccinate not only affects the person receiving (or not receiving) the 
vaccines, but also everyone around them.  Considering each individual vaccine, the 
disease/diseases they are protecting against, benefits of the vaccine, how and to whom the 
vaccine is administered, contraindications for the immunization, and risks associated with each 
vaccination, parents and caregivers can make well-informed decisions related to immunizing 
their children.  For additional information, parents and caregivers can also refer to Appendix A 
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